Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul 20;28(21):3531-40.
doi: 10.1200/JCO.2009.27.4787. Epub 2010 Jun 14.

Genetics of biliary tract cancers and emerging targeted therapies

Aram F Hezel  1 , Vikram Deshpande, Andrew X Zhu
Affiliations
Review

Genetics of biliary tract cancers and emerging targeted therapies

Aram F Hezel et al. J Clin Oncol. .

Abstract

Biliary tract cancers (BTC), which encompass intra- and extrahepatic cholangiocarcinomas and gallbladder carcinomas, are a genetically diverse collection of cancers. Evidence suggests distinct models of molecular and pathologic progression, and a growing body of genetics data points to a heterogeneous collection of underlying mutations in key oncogenes and tumor suppressor genes. Although tumor genetics have been used to tailor individual treatment regimens and guide clinical decision making in other cancers, these principles have not been applied in BTC. Recent clinical trials with targeted therapies seem promising, although the relationships between subsets of patients with positive responses to therapy and tumor genetics remain unexplored. Here, we summarize the molecular pathogenesis and genetics of BTCs and animal modeling and relate these to recent and ongoing clinical trials with targeted agents.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
Precursors to biliary tract carcinoma. (A) Biliary dysplasia of the common bile duct (biliary intraepithelial neoplasia-2 [BilIN-2]; hematoxylin and eosin [HE]). (B) Biliary dysplasia of the common bile duct (biliary intraepithelial neoplasia-3 [BilIN-3]). Compared with BilIN-2, BilIN-3 shows loss of cell polarity and marked nuclear atypia (HE). (C) Intraductal papillary neoplasm of the bile duct. This papillary neoplasm diffusely involved the intrahepatic biliary tree. The lining epithelium was of the biliary type (HE). The adjacent liver (*) was unremarkable. (D) Gallbladder adenoma lined predominantly by foveolar-type epithelium. There was no evidence of an associated invasive carcinoma (HE). (E) Severe dysplasia/carcinoma in situ of the gallbladder with involvement of Rokitansky-Aschoff sinuses (arrow). There was no evidence of invasive carcinoma (HE). (F) Invasive adenocarcinoma of the gallbladder. There is an extensive intramucosal component (smaller arrow) with focal invasion into the muscularis propria (larger arrow) (HE).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125. - PubMed
    1. Lee CH, Chang CJ, Lin YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer. 2009;100:1765–1770. - PMC - PubMed
    1. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009;49:116–123. - PMC - PubMed
    1. Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials. Br J Cancer. 2007;96:896–902. - PMC - PubMed
    1. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–1700. - PubMed

Publication types

MeSH terms

Substances